Abeona Therapeutics Enters Material Definitive Agreement
Ticker: ABEO · Form: 8-K · Filed: Jul 18, 2025 · CIK: 318306
| Field | Detail |
|---|---|
| Company | Abeona Therapeutics Inc. (ABEO) |
| Form Type | 8-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation
TL;DR
Abeona Therapeutics just signed a big deal, creating a new financial obligation. Keep an eye on this.
AI Summary
On July 18, 2025, Abeona Therapeutics Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, formerly known as Plasmath, Access Pharmaceuticals, and Chemex Pharmaceuticals, is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates a significant new financial commitment or obligation for Abeona Therapeutics, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — Entering into material definitive agreements and creating financial obligations can introduce financial risks and operational changes that warrant careful monitoring.
Key Players & Entities
- ABEONA THERAPEUTICS INC. (company) — Registrant
- PLASMATECH BIOPHARMACEUTICALS INC (company) — Former Company Name
- ACCESS PHARMACEUTICALS INC (company) — Former Company Name
- CHEMEX PHARMACEUTICALS INC (company) — Former Company Name
- July 18, 2025 (date) — Date of earliest event reported
FAQ
What type of material definitive agreement did Abeona Therapeutics Inc. enter into?
The filing states that Abeona Therapeutics Inc. entered into a material definitive agreement, but the specific details of the agreement are not provided in this excerpt.
What is the nature of the direct financial obligation created by this agreement?
The filing indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specific terms and amounts are not detailed in this section.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 18, 2025.
What are the former names of Abeona Therapeutics Inc.?
Abeona Therapeutics Inc. was formerly known as Plasmath Biopharmaceuticals Inc., Access Pharmaceuticals Inc., and Chemex Pharmaceuticals Inc.
What is the Standard Industrial Classification code for Abeona Therapeutics Inc.?
The Standard Industrial Classification code for Abeona Therapeutics Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 18, 2025 regarding ABEONA THERAPEUTICS INC. (ABEO).